// App-Quantinova.ai

2356 : Erythrocytes used as tumor antigen delivery system to target antigen-presenting cells embody an innovative approach for in situ cancer immunotherapy

Researchers

Presenter

  • Magali Cremel

Principal Investigators

  • Nathalie Guerin

  • Quitterie Barthe

  • Vanessa Bourgeaux

  • Willy Berlier

  • Francoise Horand

  • Yann Godfrin

Medical Centers

  • Erytech Pharma Inc., Lyon, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

  • Solid malignancies

Biomarkers

  • Adenomatous Polyposis Coli

  • Prostate specific antigen

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved